Dominick Esposito
Dominick Esposito has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Breck
Insight Policy Research, Arlington, VA 22209, USA
2 shared publications - Robert Skinner
Department of Health Policy, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 1200, Nashville, TN, 37203, United States
2 shared publications Kimberly Siu
Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT
1 shared publicationMai Hubbard
Mathematica Policy Research, Cambridge, MA
1 shared publicationNicole Quon
Optimer Pharmaceuticals, Jersey City, NJ
1 shared publicationSloane Frost
Mathematica Policy Research, Princeton, NJ
1 shared publication
Latest Publications
- Open Access
- 1 April 2022
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 11 (6) , 399-409
An impact evaluation of two modes of care for sickle cell disease crises
Aim:To estimate the economic impacts of increased use of specialty care infusion centers for treating adults experiencing vaso-occlusive crises.Methods:A Markov model is developed to estimate the impact of expanding use of specialty care infusion centers to treat vaso-occlusive crises compared to emergency department care.Results:Access to infusion centers for sickle cell disease could result in savings over US$1.9 billion in formal medical costs and over US$2 billion in societal costs, based on uptake assumptions over 10 years.Conclusion:Expansion of adult sickle cell disease centers across the nation could lead to considerably better economic outcomes in the form of reduced costs and hospital length of stay in addition to improved clinical outcomes as reported in the existing literature.
- 1 April 2022
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 11 (6) , 399-409
Open AccessAn impact evaluation of two modes of care for sickle cell disease crises
Aim:To estimate the economic impacts of increased use of specialty care infusion centers for treating adults experiencing vaso-occlusive crises.Methods:A Markov model is developed to estimate the impact of expanding use of specialty care infusion centers to treat vaso-occlusive crises compared to emergency department care.Results:Access to infusion centers for sickle cell disease could result in savings over US$1.9 billion in formal medical costs and over US$2 billion in societal costs, based on uptake assumptions over 10 years.Conclusion:Expansion of adult sickle cell disease centers across the nation could lead to considerably better economic outcomes in the form of reduced costs and hospital length of stay in addition to improved clinical outcomes as reported in the existing literature.
- 1 February 2022
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 11 (2) , 67-77
An economic evaluation of teledermatology care delivery for chronic skin diseases
Aim: Analyze the impact of nationwide implementation of teledermatological care for psoriasis. Methods: Develop a Markov model that estimates the impact of telehealth technology for treatment of moderate-to-severe psoriasis on health and healthcare expenditures compared with in-person clinical care. Results: Lower medical costs by US$1.5 billion and total social costs of US$4.3 billion over 5 years. Patients save more than 67 million hours in work absenteeism and travel time, valued at US$598 million. Employers save US$1.2 billion over 5 years due to decreased employee absenteeism. Conclusion: National implementation of telehealth for psoriasis care has the potential to substantially reduce both formal healthcare costs and informal costs for families and patients, while maintaining equivalent clinical outcomes as traditional in-person care.
- 1 February 2022
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 11 (2) , 67-77
An economic evaluation of teledermatology care delivery for chronic skin diseases
Aim: Analyze the impact of nationwide implementation of teledermatological care for psoriasis. Methods: Develop a Markov model that estimates the impact of telehealth technology for treatment of moderate-to-severe psoriasis on health and healthcare expenditures compared with in-person clinical care. Results: Lower medical costs by US$1.5 billion and total social costs of US$4.3 billion over 5 years. Patients save more than 67 million hours in work absenteeism and travel time, valued at US$598 million. Employers save US$1.2 billion over 5 years due to decreased employee absenteeism. Conclusion: National implementation of telehealth for psoriasis care has the potential to substantially reduce both formal healthcare costs and informal costs for families and patients, while maintaining equivalent clinical outcomes as traditional in-person care.
- 27 June 2013
- Published by Wolters Kluwer Health in American Journal of Medical Quality
- Vol. 29 (3) , 206-212
Association Between Outpatient Visits Following Hospital Discharge and Readmissions Among Medicare Beneficiaries With Atrial Fibrillation and Other Chronic Conditions
Atrial fibrillation (AF) afflicts nearly 3 million people in the United States annually, the large majority of whom are Medicare beneficiaries with other chronic illnesses. Beneficiaries with multiple chronic conditions have high hospitalization and readmission rates but evidence on factors associated with readmissions is limited, and little is known about differences in rates between beneficiaries with and without AF. In a retrospective analysis of Medicare claims data, the relationship between outpatient visits within 14 days after hospital discharge and readmission was examined for beneficiaries with AF or other chronic conditions. About half of those beneficiaries with a hospitalization had an outpatient visit within 14 days of discharge. Readmission rates were 11% to 24% lower for beneficiaries with an outpatient visit than for those without one (P < .01). These findings suggest that follow-up care shortly after discharge may lower readmissions for patients with AF or other chronic conditions.
- 27 June 2013
- Published by Wolters Kluwer Health in American Journal of Medical Quality
- Vol. 29 (3) , 206-212
Association Between Outpatient Visits Following Hospital Discharge and Readmissions Among Medicare Beneficiaries With Atrial Fibrillation and Other Chronic Conditions
Atrial fibrillation (AF) afflicts nearly 3 million people in the United States annually, the large majority of whom are Medicare beneficiaries with other chronic illnesses. Beneficiaries with multiple chronic conditions have high hospitalization and readmission rates but evidence on factors associated with readmissions is limited, and little is known about differences in rates between beneficiaries with and without AF. In a retrospective analysis of Medicare claims data, the relationship between outpatient visits within 14 days after hospital discharge and readmission was examined for beneficiaries with AF or other chronic conditions. About half of those beneficiaries with a hospitalization had an outpatient visit within 14 days of discharge. Readmission rates were 11% to 24% lower for beneficiaries with an outpatient visit than for those without one (P < .01). These findings suggest that follow-up care shortly after discharge may lower readmissions for patients with AF or other chronic conditions.